Low-risk DCIS patients may safely skip radiotherapy after surgery, study finds

[News]

Patients with low-risk ductal carcinoma in situ (DCIS) who skipped adjuvant radiotherapy after breast-conserving surgery had comparable five-year outcomes to those with high-risk DCIS who received adjuvant radiotherapy, according to results from the E4112 clinical trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.

More... (https://www.news-medical.net/news/20231208/Low-risk-DCIS-patients-may-safely-skip-radiotherapy-after-surgery-study-finds.aspx)